Company Filing History:
3 out of 2,077 
1 out of 76 
1 out of 363 
Years Active: 2003-2014
Title: **Ingrid Christa Deckman: Innovator in Matrix Metalloproteinase Inhibitors**
Introduction
Ingrid Christa Deckman, based in Berwyn, PA (US), is a prominent inventor known for her significant contributions to the field of biochemistry, particularly in the development of treatments targeting matrix metalloproteinases (MMPs). With five patents to her name, her innovations have the potential to revolutionize therapies for various diseases related to abnormal MMP activity.
Latest Patents
Her latest patents encompass groundbreaking methods of treatment using small-molecule allosteric processing inhibitors for matrix metalloproteinases. One notable invention includes a crystal structure comprising a complex of the pro form of a matrix metalloproteinase (proMMP) and an allosteric processing inhibitor, which effectively hinders the activation of proMMPs. This innovation focuses on the crystal structure of proMMP9 bound to a small-molecule inhibitor, paving the way for developing targeted treatments for diseases stemming from inappropriate MMP activity.
Career Highlights
Ingrid has worked with renowned companies such as Janssen Pharmaceutica and 3-Dimensional Pharmaceuticals, Inc. Throughout her career, she has developed essential methodologies for designing and optimizing allosteric processing inhibitors, significantly enhancing the landscape of therapeutic interventions for conditions linked to MMPs. Her work embodies a blend of scientific excellence and practical application within drug development.
Collaborations
Ingrid Deckman has collaborated with several distinguished professionals in her field, including John Curtis Spurlino and Kristi A. Leonard. These partnerships have contributed to the advancement of her research and patents, resulting in innovative approaches to combating diseases associated with MMPs.
Conclusion
Ingrid Christa Deckman's work stands at the forefront of biomedical innovation. Her expertise in matrix metalloproteinases and the development of allosteric processing inhibitors highlight her role as a vital contributor to medical advancements. With her impressive array of patents and collaborations, she continues to influence the direction of treatment methodologies in this critical area of health science.